In today's episode, we’re going to talk about the approval of Gavreto, a new gene specific treatment for non-small cell lung cancer, and approval of Qdolo a new oral solution for pain management. We’ll also be discussing approval of new dosing guidelines for Trulicity which will also prompt new strengths available on the market. Don't forget to like, share, and subscribe! Enjoy!